Patterson Q4 2024 Earnings Report
Key Takeaways
Patterson Companies reported a slight increase in net sales for the fourth quarter of fiscal year 2024, with strong performances in dental consumables and production animal businesses offsetting declines in other areas. The company's GAAP earnings were $0.74 per diluted share, while adjusted earnings were $0.82 per diluted share, both negatively impacted by the Change Healthcare cybersecurity attack.
Net sales increased 0.1% year-over-year to $1.72 billion, while internal sales decreased 0.5%.
Dental consumables grew 3.7% year-over-year.
GAAP earnings were $0.74 per diluted share, and adjusted earnings were $0.82 per diluted share.
Cybersecurity attack on Change Healthcare negatively impacted GAAP and adjusted earnings by $0.04 per diluted share.
Patterson
Patterson
Patterson Revenue by Segment
Forward Guidance
Patterson Companies initiated its fiscal 2025 earnings guidance, which is provided on both a GAAP and non-GAAP adjusted basis.
Positive Outlook
- GAAP earnings are expected to be in the range of $2.00 to $2.10 per diluted share.
- Non-GAAP adjusted earnings are expected to be in the range of $2.33 to $2.43 per diluted share.
- Guidance reflects the strength of our business and competitive positioning.
- Guidance reflects completed and previously announced acquisitions.
- Guidance assumes North American and international end market conditions consistent with current market conditions.
Challenges Ahead
- Guidance does not include the impact of unplanned share repurchases.
- Guidance does not include potential future acquisitions or similar transactions.
- Guidance does not include impairments.
- Guidance does not include restructuring and integration expenses not previously publicly disclosed.
- Guidance does not include amortization expense of acquired intangible assets.
Revenue & Expenses
Visualization of income flow from segment revenue to net income